BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller L, Birks E, Guglin M, Lamba H, Frazier OH. Use of Ventricular Assist Devices and Heart Transplantation for Advanced Heart Failure. Circ Res 2019;124:1658-78. [PMID: 31120817 DOI: 10.1161/CIRCRESAHA.119.313574] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Sasaki D, Abe J, Takeda A, Harashima H, Yamada Y. Transplantation of MITO cells, mitochondria activated cardiac progenitor cells, to the ischemic myocardium of mouse enhances the therapeutic effect. Sci Rep 2022;12:4344. [PMID: 35318358 DOI: 10.1038/s41598-022-08583-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hullin R, Meyer P, Yerly P, Kirsch M. Cardiac Surgery in Advanced Heart Failure. J Clin Med 2022;11:773. [PMID: 35160225 DOI: 10.3390/jcm11030773] [Reference Citation Analysis]
3 Ryan CT, Patel V, Rosengart TK. Clinical potential of angiogenic therapy and cellular reprogramming. JTCVS Open 2021;6:108-15. [PMID: 34746874 DOI: 10.1016/j.xjon.2020.12.023] [Reference Citation Analysis]
4 Obi C, Smith AT, Hughes GJ, Adeboye AA. Targeting mitochondrial dysfunction with elamipretide. Heart Fail Rev 2022. [PMID: 35037146 DOI: 10.1007/s10741-021-10199-2] [Reference Citation Analysis]
5 Tie H, Shi R, Welp H, Martens S, Li Z, Sindermann J, Martens S. C-reactive protein predicts early clinical outcomes and long-term mortality after left ventricular assisted device. Int J Artif Organs 2022;:3913988221088614. [PMID: 35388731 DOI: 10.1177/03913988221088614] [Reference Citation Analysis]
6 Machino T, Sato A, Murakoshi N, Ieda M. Phase I investigator-initiated study of the safety of MTC001 in patients with chronic ischemic heart failure. Medicine (Baltimore) 2021;100:e28372. [PMID: 34941159 DOI: 10.1097/MD.0000000000028372] [Reference Citation Analysis]
7 Yadid M, Oved H, Silberman E, Dvir T. Bioengineering approaches to treat the failing heart: from cell biology to 3D printing. Nat Rev Cardiol 2021. [PMID: 34453134 DOI: 10.1038/s41569-021-00603-7] [Reference Citation Analysis]
8 Tang PC. Editorial commentary: Durable mechanical circulatory support, the challenges ahead. Trends Cardiovasc Med 2020;30:230-1. [PMID: 31229397 DOI: 10.1016/j.tcm.2019.06.002] [Reference Citation Analysis]
9 Li H, Chen Y, Jin Q, Wu Y, Deng C, Gai Y, Sun Z, Li Y, Wang J, Yang Y, Lv Q, Zhang Y, An R, Lan X, Zhang L, Xie M. Noninvasive Radionuclide Molecular Imaging of the CD4-Positive T Lymphocytes in Acute Cardiac Rejection. Mol Pharm 2021;18:1317-26. [PMID: 33506680 DOI: 10.1021/acs.molpharmaceut.0c01155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Severino P, Mather PJ, Pucci M, D'Amato A, Mariani MV, Infusino F, Birtolo LI, Maestrini V, Mancone M, Fedele F. Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist. Diagnostics (Basel) 2019;9:E170. [PMID: 31683887 DOI: 10.3390/diagnostics9040170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
11 Isaza N, Gonzalez M, Saijo Y, Vega Brizneda M, Estep J, Starling RC, Albert C, Soltesz E, Tong MZ, Smedira N, Grimm RA, Griffin BP, Popovic ZB, Xu B. Incremental Value of Global Longitudinal Strain to Michigan Risk Score and Pulmonary Artery Pulsatility Index in Predicting Right Ventricular Failure Following Left Ventricular Assist Devices. Heart Lung Circ 2022:S1443-9506(22)00144-5. [PMID: 35491337 DOI: 10.1016/j.hlc.2022.03.012] [Reference Citation Analysis]
12 Borow KM, Yaroshinsky A, Greenberg B, Perin EC. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circ Res. 2019;125:265-281. [PMID: 31318648 DOI: 10.1161/circresaha.119.314951] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
13 Truesdell AG. The Contemporary Cardiogenic Shock ‘Playbook’. US Cardiology Review 2021;15:e24. [DOI: 10.15420/usc.2020.28] [Reference Citation Analysis]
14 López-Vilella R, González-Vílchez F, Crespo-Leiro MG, Segovia-Cubero J, Cobo M, Delgado-Jiménez J, Arizón Del Prado JM, Martínez-Sellés M, Sobrino Márquez JM, Mirabet-Pérez S, González-Costello J, Pérez-Villa F, Lambert-Rodríguez JL, Rábago-Aracil G, Blasco-Peiró MT, de la Fuente-Galán L, Garrido-Bravo I, Otero D, Almenar-Bonet L. Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry. Rev Esp Cardiol (Engl Ed) 2021;74:393-401. [PMID: 32600994 DOI: 10.1016/j.rec.2020.02.016] [Reference Citation Analysis]
15 Borchers P, Winnersbach P, Kraemer S, Beckers C, Buhl EM, Leonhardt S, Rossaint R, Walter M, Breuer T, Bleilevens C. Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit. J Clin Med 2022;11:3431. [PMID: 35743501 DOI: 10.3390/jcm11123431] [Reference Citation Analysis]
16 López-vilella R, González-vílchez F, Crespo-leiro MG, Segovia-cubero J, Cobo M, Delgado-jiménez J, Arizón del Prado JM, Martínez-sellés M, Sobrino Márquez JM, Mirabet-pérez S, González-costello J, Pérez-villa F, Lambert-rodríguez JL, Rábago-aracil G, Blasco-peiró MT, de la Fuente-galán L, Garrido-bravo I, Otero D, Almenar-bonet L. Impacto de la edad del donante-receptor en la supervivencia al trasplante cardiaco. Subanálisis del Registro Español de Trasplante Cardiaco. Revista Española de Cardiología 2021;74:393-401. [DOI: 10.1016/j.recesp.2020.02.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Du Y, Duan C, Yang Y, Yuan G, Zhou Y, Zhu X, Wei N, Hu Y. Heart Transplantation: A Bibliometric Review From 1990-2021. Curr Probl Cardiol 2022;:101176. [PMID: 35341797 DOI: 10.1016/j.cpcardiol.2022.101176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 James EC, Tomaskovic-Crook E, Crook JM. Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells. Int J Mol Sci 2021;22:3005. [PMID: 33809429 DOI: 10.3390/ijms22063005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Roth S, M'Pembele R, Stroda A, Voit J, Lurati Buse G, Sixt SU, Westenfeld R, Polzin A, Rellecke P, Tudorache I, Hollmann MW, Boeken U, Akhyari P, Lichtenberg A, Huhn R, Aubin H. Days alive and out of hospital after left ventricular assist device implantation. ESC Heart Fail 2022. [PMID: 35513994 DOI: 10.1002/ehf2.13942] [Reference Citation Analysis]
20 Notarianni A, Tickoo M, Bardia A. Mechanical Cardiac Circulatory Support: an Overview of the Challenges for the Anesthetist. Curr Anesthesiol Rep 2021;:1-8. [PMID: 34611458 DOI: 10.1007/s40140-021-00486-x] [Reference Citation Analysis]
21 Cardenas-Alvarez JL, Suarez J, Motoa G, Anjan S, Natori Y, Loebe M, Breda JR, Thakkar-Rivera N, Phancao A, Ghodsizad A, Bauerlein JE, Munagala MR, Simkins J. Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series. J Card Surg 2021;36:4786-8. [PMID: 34599521 DOI: 10.1111/jocs.16040] [Reference Citation Analysis]
22 Al-Adhami A, Avtaar Singh SS, De SD, Singh R, Panjrath G, Shah A, Dalzell JR, Schroder J, Al-Attar N. Primary Graft Dysfunction after Heart Transplantation - Unravelling the Enigma. Curr Probl Cardiol 2021;:100941. [PMID: 34404551 DOI: 10.1016/j.cpcardiol.2021.100941] [Reference Citation Analysis]